307 related articles for article (PubMed ID: 33493106)
1. Prevalence of SARS-CoV-2 Antibodies in First Responders and Public Safety Personnel, New York City, New York, USA, May-July 2020.
Sami S; Akinbami LJ; Petersen LR; Crawley A; Lukacs SL; Weiss D; Henseler RA; Vuong N; Mackey L; Patel A; Grohskopf LA; Morgenthau BM; Daskalakis D; Pathela P
Emerg Infect Dis; 2021 Mar; 27(3):796-804. PubMed ID: 33493106
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 Seroprevalence among Healthcare, First Response, and Public Safety Personnel, Detroit Metropolitan Area, Michigan, USA, May-June 2020.
Akinbami LJ; Vuong N; Petersen LR; Sami S; Patel A; Lukacs SL; Mackey L; Grohskopf LA; Shehu A; Atas J
Emerg Infect Dis; 2020 Dec; 26(12):2863-2871. PubMed ID: 32956614
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Following the Largest Initial Epidemic Wave in the United States: Findings From New York City, 13 May to 21 July 2020.
Pathela P; Crawley A; Weiss D; Maldin B; Cornell J; Purdin J; Schumacher PK; Marovich S; Li J; Daskalakis D;
J Infect Dis; 2021 Jul; 224(2):196-206. PubMed ID: 33836067
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of SARS-CoV-2 Antibodies in New York City Adults, June-October 2020: A Population-Based Survey.
Parrott JC; Maleki AN; Vassor VE; Osahan S; Hsin Y; Sanderson M; Fernandez S; Levanon Seligson A; Hughes S; Wu J; DeVito AK; LaVoie SP; Rakeman JL; Gould LH; Alroy KA
J Infect Dis; 2021 Jul; 224(2):188-195. PubMed ID: 34086923
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States.
Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M
PLoS One; 2021; 16(6):e0243676. PubMed ID: 34111144
[TBL] [Abstract][Full Text] [Related]
6. Disparities in Seroprevalence of SARS-CoV-2 Immunoglobulin Antibodies in a Large Midwestern Health Care System.
Fitzpatrick V; Rivelli A; Blair C; Copeland K; Richards J
Public Health Rep; 2021 May; 136(3):361-367. PubMed ID: 33673779
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada.
Saeed S; Drews SJ; Pambrun C; Yi QL; Osmond L; O'Brien SF
Transfusion; 2021 Mar; 61(3):862-872. PubMed ID: 33527398
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020.
Shakiba M; Nazemipour M; Salari A; Mehrabian F; Nazari SSH; Rezvani SM; Ghasempour Z; Heidarzadeh A; Mansournia MA
Emerg Infect Dis; 2021 Feb; 27(2):636-638. PubMed ID: 33349310
[TBL] [Abstract][Full Text] [Related]
9. Underascertainment of COVID-19 cases among first responders: a seroepidemiological study.
Backhaus I; Hermsen D; Timm J; Boege F; Lübke N; Göbels K; von der Lieth D; Dragano N
Occup Med (Lond); 2022 Apr; 72(3):225-228. PubMed ID: 34882771
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of SARS-CoV-2-Specific Antibodies, Japan, June 2020.
Yoshiyama T; Saito Y; Masuda K; Nakanishi Y; Kido Y; Uchimura K; Mitarai S; Suzuki T; Nakagama Y; Kubota H; Satomi M; Uchikoba S; Ohnishi M; Wakita T; Kato S; Kato K
Emerg Infect Dis; 2021 Feb; 27(2):628-631. PubMed ID: 33496235
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study.
Anand S; Montez-Rath M; Han J; Bozeman J; Kerschmann R; Beyer P; Parsonnet J; Chertow GM
Lancet; 2020 Oct; 396(10259):1335-1344. PubMed ID: 32987007
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of SARS-CoV-2-Specific IgG Antibodies Among Adults Living in Connecticut: Post-Infection Prevalence (PIP) Study.
Mahajan S; Srinivasan R; Redlich CA; Huston SK; Anastasio KM; Cashman L; Massey DS; Dugan A; Witters D; Marlar J; Li SX; Lin Z; Hodge D; Chattopadhyay M; Adams MD; Lee C; Rao LV; Stewart C; Kuppusamy K; Ko AI; Krumholz HM
Am J Med; 2021 Apr; 134(4):526-534.e11. PubMed ID: 33130124
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 Infection and Mitigation Efforts among Office Workers, Washington, DC, USA.
Sami S; Vuong N; Miller H; Priestley R; Payne M; Licata-Portentoso G; Drobeniuc J; Petersen LR
Emerg Infect Dis; 2021 Feb; 27(2):669-672. PubMed ID: 33496649
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of COVID-19 IgG Antibodies in a Cohort of Municipal First Responders.
McGuire SS; Klassen AB; Heywood J; Sztajnkrycer MD
Prehosp Disaster Med; 2021 Apr; 36(2):131-134. PubMed ID: 33397545
[TBL] [Abstract][Full Text] [Related]
15. Coronavirus Disease 2019 Exposure in Surgeons and Anesthesiologists at a New York City Specialty Hospital: A Cross-Sectional Study of Symptoms and SARS-CoV-2 Antibody Status.
Soffin EM; Reisener MJ; Padgett DE; Kelly BT; Sama AA; Zhu J; Salzmann SN; Chiapparelli E; Okano I; Oezel L; Miller AO; Cammisa FP; Girardi FP; Hughes AP
J Occup Environ Med; 2021 Jun; 63(6):521-527. PubMed ID: 34048384
[TBL] [Abstract][Full Text] [Related]
16. Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City.
Stadlbauer D; Tan J; Jiang K; Hernandez MM; Fabre S; Amanat F; Teo C; Arunkumar GA; McMahon M; Capuano C; Twyman K; Jhang J; Nowak MD; Simon V; Sordillo EM; van Bakel H; Krammer F
Nature; 2021 Feb; 590(7844):146-150. PubMed ID: 33142304
[TBL] [Abstract][Full Text] [Related]
17. Assessment of 135 794 Pediatric Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 Across the United States.
Bailey LC; Razzaghi H; Burrows EK; Bunnell HT; Camacho PEF; Christakis DA; Eckrich D; Kitzmiller M; Lin SM; Magnusen BC; Newland J; Pajor NM; Ranade D; Rao S; Sofela O; Zahner J; Bruno C; Forrest CB
JAMA Pediatr; 2021 Feb; 175(2):176-184. PubMed ID: 33226415
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 Seroprevalence Among Healthcare Workers by Job Function and Work Location in a New York Inner-City Hospital.
Purswani MU; Bucciarelli J; Tiburcio J; Yagudayev SM; Connell GH; Omidiran AA; Hannaway L; Zeana C; Healy M; Yu G; Reich D
J Hosp Med; 2021 May; 16(5):282-289. PubMed ID: 33929948
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare workers with differing levels of coronavirus disease 2019 (COVID-19) patient exposure.
Hunter BR; Dbeibo L; Weaver CS; Beeler C; Saysana M; Zimmerman MK; Weaver L
Infect Control Hosp Epidemiol; 2020 Dec; 41(12):1441-1442. PubMed ID: 32741406
[TBL] [Abstract][Full Text] [Related]
20. Severe Acute Respiratory Syndrome Coronavirus 2 Seropositivity among Healthcare Personnel in Hospitals and Nursing Homes, Rhode Island, USA, July-August 2020.
Akinbami LJ; Chan PA; Vuong N; Sami S; Lewis D; Sheridan PE; Lukacs SL; Mackey L; Grohskopf LA; Patel A; Petersen LR
Emerg Infect Dis; 2021 Mar; 27(3):823-834. PubMed ID: 33622481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
